BioVie (NASDAQ:BIVI) stock is falling on Monday after the biopharmaceutical company revealed details for a public stock offering.
BioVie has priced its shares at $1 each in the public offering. Twenty-one million shares are being sold, and they come with warrants for another 10.5 million shares of BIVI stock. Investors will note the warrants have an exercise price of $1.50 each.
BioVie expects to raise $1 million in gross proceeds from the public offering. The company will use these funds for working capital and general corporate purposes. ThinkEquity is the sole placement agent for the offering.
How This Affects BIVI Stock
A public stock offering increases the total number of outstanding BIVI shares. That’s worth noting as it also dilutes the stakes of current investors in BioVie. That’s one reason the stock is falling this morning.
The public offering price of $1 per share is another sticking point for investors. It’s a significant discount over the stock’s prior closing price of $1.89 per share. The same holds true for the warrant exercise price.
BIVI stock is down 41.3% as of Monday morning after the shares experienced a 52.4% rally on Friday.
Investors who are seeking out even more of the most recent stock market stories will want to stick around!
We have all of the hottest stock market news that traders need to know about on Monday! A few examples include what’s going on with shares of Ainos (NASDAQ:AIMD) and BitFuFu (NASDAQ:FUFU) shares, as well as the biggest pre-market stock movers this morning. All of this news is ready to go at the links below!
More Monday Stock Market News
- Why Is Ainos (AIMD) Stock Up 57% Today?
- Why Is BitFuFu (FUFU) Stock Up 109% Today?
- Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com’s writers disclose this fact and warn readers of the risks.
Read More: Penny Stocks — How to Profit Without Getting Scammed
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
